Psychedelics biotech Eleusis has its eyes on an expansion, and it’s going the SPAC route to get it. The biotech...
CAPE TOWN, SA / ACCESSWIRE / January 19, 2022 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“WGG” or the “Company”), a bioceutical company focused...
Pfizer released data from several studies showing that nirmatrelvir, the active main protease inhibitor of the company's antiviral combination therapy...
Revive Therapeutics (CSE: RVV) provided on Tuesday updates regarding the phase 3 clinical trial for oral drug bucillamine as a treatment The post Revive...
The year 2021 has not been kind to the psychedelics industry. The stock performances of the 60 publicly traded psychedelics companies on the Psychedelic...
Registry Direct has reported strong metrics in Q2 FY22 as it works on improving its platform and looks for growth ... Read More The post Registry...
Introduction You may know Psychedelic Invest for our trackable index of public companies. You may know us for our constant stream of informative content...
A new survey conducted by The Harris Poll on behalf of Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (Original Source), a leader in new medicines and...
The article Update on Revive Therapeutics Psilocybin Programs was originally published on Microdose. Part of the first wave of publicly-traded companies...
Recent advances in brain imaging techniques facilitate accurate, high-resolution observations of the brain and its functions. For example, functional near-infrared...
